Proffitt & Goodson’s Merck MRK Stock Holding History

Proffitt & Goodson’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54K	Buy	+12	New	+$1.41K	﹤0.01%	287
2025 Q4	–	Sell	-138	Closed	-$11.6K	–	387
2025 Q3	$11.6K	Hold	138	–	–	﹤0.01%	240
2025 Q2	$10.9K	Hold	138	–	–	﹤0.01%	207
2025 Q1	$12.4K	Hold	138	–	–	﹤0.01%	199
2024 Q4	$13.7K	Sell	138 -36	-21%	-$3.71K	﹤0.01%	189
2024 Q3	$19.8K	Sell	174 -23	-12%	-$2.73K	﹤0.01%	195
2024 Q2	$24.4K	Buy	+197	New	+$25.4K	﹤0.01%	191
2022 Q2	–	Sell	-250	Closed	-$21K	–	272
2022 Q1	$21K	Hold	250	–	–	﹤0.01%	205
2021 Q4	$19K	Hold	250	–	–	﹤0.01%	190
2021 Q3	$19K	Hold	250	–	–	﹤0.01%	186
2021 Q2	$19K	Sell	250 -12	-5%	-$893	﹤0.01%	198
2021 Q1	$19K	Sell	262 -32	-11%	-$2.36K	﹤0.01%	195
2020 Q4	$23K	Hold	294	–	–	﹤0.01%	175
2020 Q3	$23K	Hold	294	–	–	﹤0.01%	167
2020 Q2	$22K	Buy	294 +262	+819%	+$19.7K	﹤0.01%	172
2020 Q1	$2K	Hold	32	–	–	﹤0.01%	205
2019 Q4	$3K	Hold	32	–	–	﹤0.01%	198
2019 Q3	$3K	Hold	32	–	–	﹤0.01%	186
2019 Q2	$3K	Hold	32	–	–	﹤0.01%	179
2019 Q1	$3K	Buy	+32	New	+$2.39K	﹤0.01%	176

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Proffitt & Goodson's MRK Position: Q2 2026 in Review

Proffitt & Goodson opened a new position in Merck (MRK) in Q2 2026: 12 shares worth $1.54K. The stake represents ﹤0.01% of the portfolio and ranks #287 among its holdings. This is a return to the name: Proffitt & Goodson previously reported a position in MRK as recently as Q3 2025.

Proffitt & Goodson first reported a position in MRK in Q1 2019 and has held it in 20 quarters since. The position peaked at $24.4K in Q2 2024. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Proffitt & Goodson held 12 shares of Merck worth $1.54K as of Q2 2026.
Merck was a new Proffitt & Goodson position in Q2 2026.
Merck made up ﹤0.01% of Proffitt & Goodson's portfolio in Q2 2026, its #287 holding.
Proffitt & Goodson first reported a position in Merck in Q1 2019 and has held it in 20 quarters since.
Proffitt & Goodson's Merck position peaked at $24.4K in Q2 2024.
3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Proffitt & Goodson's 13F filing for Q2 2026, filed 22 Jul 2026.